Materials and Methods
Cell Cultures. Mouse L929 cells and human Flow 5000 cells were purchased from Flow Laboratories, Inc., McLean, VA, and mouse 3T3-A31 cells were purchased from the American Type Culture Collection, Rockville, MD. Cultures of human foreskin fibroblasts were obtained from Mr. Frank Pindak, University of South Alabama.
L929 cells were grown in Eagle's minimum essential medium supplemented with 10% calf serum; 3T3-A31 cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% calf serum; and Flow 5000 cells and human foreskin fibroblasts were grown in Eagle's minimum essential medium supplemented with 10% fetal calf serum. Calf and fetal calf sera were heat inactivated at 56°C before use. All cell cultures were grown in tissue culture dishes or flasks in a CO2 incubator at 34°C.
Rickettsiae. R. prowazekii was grown in 6-d embryonated, antibiotic-free hen eggs (Truslow Farms, Chestertown, MD) inoculated from seed pools prepared from the E strain or the Breinl strain. Rickettsiae were harvested and purified from infected yolk sacs 8 d after inoculation by methods modified from those of Bovarnick and Snyder (14) and Wisseman et al. (15) , as described previously (16) . The rickettsiae were then passed through a type AP20 microfilter glass filter (Millipore Corp., Bedford, MA) (17, 18) and were stored at -70°C in 0.2-ml aliquots. Viable rickettsiae were enumerated by the antibody hemolysis method of Walker and Winkler (19) .
Preparation of Lymphokines.
Mouse lymphokines were prepared by three procedures. In the first procedure, spleen cells obtained from male BALB/c mice (16-32 wk old) were adjusted to a concentration of 5 × 106 cells/ml in RPMI 1640 medium supplemented with 5% fetal calf serum and incubated with 0.6-1.5 #g/ml concanavalin A (Sigma Chemical Co., St. Louis, MO). Alternatively, spleen cells were obtained from mice immunized 7 d previously by intraperitoneal injection of 1.4 mg heat-killed Corynebacterium paroum CN6134 (Burroughs Wellcome Co., Research Triangle Park, NC) and were incubated with 14/zg/ml (dry weight)
heat-killed C. parvum. In the third procedure, spleen cells were obtained from mice immunized 7 d previously by intraperitoneal injection of 105-106 viable rickettsiae (E strain, R. prowazeki 0 and were incubated with heat-killed R. prowazekii E strain at a concentration of 14 /zg of rickettsial protein/ml.
All spleen cell suspensions were prepared according to the method of Ruco and Meltzer (20) . After incubation of the cultures at 34°C for 48 h, the culture fluids were centrifuged and sterilized by filtration (pore size, 0.2 #m). The culture fluids (crude mouse lymphokines) were stored at 4°C or -70°C.
For human lymphokine production, tymphocytes and monocytes were isolated from ethylenediamine tetraacetate-treated human blood samples by centrifugation of the diluted blood over FicolbPaque (Pharmacia Fine Chemicals, Piscataway, N J). The lymphocytes and monocytes were washed and resuspended at a concentration of 1 X 106 cells/ml in RPMI 1640 medium supplemented with 5% fetal calf serum. The cells were incubated with 1.5 /zg/ml concanavalin A for 72 h at 34°C. Supernatant fluids (crude human lymphokines) were collected and stored at 4°C.
Treatment of Cells with Lymphokines and Infection of Cells with
Rickettsiae. All cells were xirradiated with a General Electric Maximar 100 X-ray unit at a dosage adequate to prevent cell division (3,000-5,000 tad). After irradiation, the cell lines L929, 3T3-A31, Flow 5000, and human foreskin fibroblasts were adjusted to a density of 1.0-1.2 × 105 viable (trypan blueexcluding) cells/ml and were planted in eight-chambered slides (0.3 ml/ehamber) (Lab-Tek Div., Miles Laboratories Inc., Naperville, IL). The cells were incubated overnight in a CO2 incubator at 34°C. The culture medium was then removed and the cells were treated with medium alone or with various dilutions of lymphokines in tissue culture medium. After incubation for an additional 24 h, the cells were infected with rickettsiae.
Rickettsiae were diluted in Hanks' balanced salt solution supplemented with 0.1% gelatin and 4.9 mM L-glutamic acid (monopotassium salt). Rickettsiae were added to washed cells at multiplicities of 100-400 viable rickettsiae per cell. Cells and rickettsiae were incubated together for 1 h at 34°C. The cells were then washed twice and given fresh tissue culture medium or lymphokines diluted in tissue culture medium. Infected cells were incubated at 34°C for up to 48 h. At 0, 24, and 48 h after infection, chamber slides were washed gently in 0.85% NaCI and
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were dried with a warm air stream. Slides were fixed in 1% formalin in 0.1 M sodium phosphate buffer, pH 6.8. The slides were washed in three changes of buffer and were then stained by a modification of the Gimenez method, as described by Wisseman et al. (21) .
Similar experiments were conducted in 24-well plates (Flow Laboratories, Inc.) that contained cover glasses. In these experiments the tissue culture medium in each well (1 ml) was cytocentrifuged onto a microscope slide in a Cytospin SCA-0031 (Shandon Southern Instruments Inc., Sewickley, PA). The resultant slides as well as the cover glasses from the wells were fixed and stained as described above. A small number of cells was present in the smears prepared by cytocentrifugation of the tissue culture medium collected from both control and lymphokine-treated wells. The approximate number of cells in the medium was estimated by counting the number of cells in a measured area of each smear and comparing it with the numbers of ceils present in the same areas of smears prepared from known numbers of cells.
All treatments were done in duplicate at each time point. Slides were examined microscopically with an oil immersion objective, and the number of rickettsiae present in each of 100 cells was counted for each duplicate of each treatment. When a cell contained >100 rickettsiae it was assigned a value of 100; this practice causes an underestimate of the number of rickettsiae at later times. The percentage of cells infected with rickettsiae (%R), t the average number of rickettsiae per infected cell (RI), and the average number of rickettsiae per cell (NR), were determined. Many of the data were normalized to the zero time infection, e.g., RI at a given time divided by RI at zero time multiplied by 100 gives the average number of rickettsiae per infected cell as a percentage of that observed at zero time.
Experiments with Lymphokines and Inhibitors of Eukaryotic Protein Synthesis, Irradiated L929 cells
were treated with tissue cuhure medium alone, medium plus lymphokines, medium plus lymphokines and inhibitor (cycloheximide, 1 ~g/ml, or emetine, 0.5 p.g/ml), or medium plus inhibitor. Rickettsial growth was monitored as described above. Percent inhibition of rickettsial growth in lymphokine-treated chambers (%LK) and percent inhibition of rickettsial growth in lymphokine plus inhibitor-treated chambers (%LKIN) were calculated as follows from the values of NR at 48 h after infection (expressed as percentages of the values of NR observed at 0 h): %LK = [(NR control chambers -NR lymphokine-treated chambers)/NR control chambers] X t00. %LKIN = [(NR inhibitor-treated chambers -NR lymphokine plus inhibitortreated chambers)/NR inhibitor-treated chambers] × 100. Percent suppression of the antirickettsial effect of the lymphokines by the inhibitor was calculated from the difference between %LK and %LKIN.
Rapid Method for Assay of Anti-Rickettsial Activity (ARA ) in Mouse l~ymphokines. Irradiated L929 cells were treated before and after rickettsial infection with dilutions of the lymphokine preparation to be assayed and were examined 48 h after infection with rickettsiae. A cell was scored positive for rickettsial growth if it contained 10 or more rickettsiae, and negative if it contained 9 or fewer rickettsiae. At 48 h after infection, 60-90% of the cells in the control chambers were positive for rickettsial growth whereas at 0 h, <5% of the cells had been positive by this criterion. Percent inhibition of rickettsial growth was calculated from the difference between the percentages of positive cells in control and treated chambers. The amount of lymphokine that would cause 50% inhibition of rickettsial growth in a slide chamber (0.3 ml) was defined as 1 U of ARA.
Results

Effect of Mouse Lymphokine Treatment of L929 Cells on their b~teraction with R. prowazekii (E Strain).
The time at which lymphokines were presented was an important factor in determining the degree of rickettsial clearance and inhibition of rickettsial growth in lymphokine-treated L929 cells. Fig. 1 shows the results of several experiments in which %R and RI were monitored at 0, 24, and 48 h after rickettsial infection in L929 cells treated with lymphokines before infection, after infection, or before and after Abbreviations used in this paper: ARA, anti-rickettsial activity; %LK, percent inhibition of rickettsial growth in lymphokine-treated chambers; ~7~I,KIN, percent inhibition of rickettsial growth in lymphokine plus inhibitor-treated chambers; NR, average number of rickettsiae per cell; RI, average number of rickettsiae per infected cell: %R, percentage of cells infected with rickettsiae. infection. Decreases in %R relative to the values observed at zero time indicate total clearance of rickettsiae from some of the cells. Treatment of L929 cells with iymphokines for 24 h before rickettsial infection resulted in complete clearance of rickettsiae from more than one-half of the infected cells by 24 h after infection. %R remained about the same during the next 24 h in cells treated with lymphokines only before infection, but this parameter continued to decrease in cells treated with lymphokines both before and after infection. When lymphokines were present only after rickettsial infection, there was a slower and less pronounced decrease in %R.
During the 48 h period after infection, RI, an index of rickettsial growth, increased 19-fold in control cultures (Fig. 1) . However, in cells treated with lymphokines both before and after infection, RI underwent little change. Thus rickettsial growth was almost completely inhibited in the lymphokine-treated cells that remained infected. Partial inhibition of rickettsial growth was observed when L929 cells were treated with lymphokines either only before or only after infection. In ceils pretreated with lymphokines for 24 h before infection rickettsial growth was most suppressed during the first 24 h after infection. In contrast, in cells treated with lymphokines only after infection the most marked inhibition was apparent during the period from 24 to 48 hr after infection.
Examination ofcytocentrifuged preparations from the tissue culture media revealed the presence of small numbers of suspended L929 cells in both control and lymphokine-treated culture fluids. The cells present in the culture fluids represented 6-14% of the total cells in the cultures. Rickettsial growth was evident in many of the cells present in the smears prepared from control cultures but not in the cells present in the smears prepared from lymphokine-treated cultures.
The effect of pretreatment of L929 cells with lymphokines for 24 h on the ability of the cells to be initially infected with rickettsiae was variable. In 46 experiments the average %R at 0 h were 83 + 2% and 71 + 3% in control and lymphokine-treated cells, respectively. RI at 0 h were 3.7 + 0.2 for the control cells and 2.9 +_ 0.2 for the lymphokine-treated cells. Although these mean values did not reveal dramatic differences between the control and lymphokine-treated groups, the data from individual experiments showed that the RI in lymphokine-treated cultures was <75% of that in control cultures in 24 of the 46 experiments.
Inhibition of the Growth of R. prowazekii (Avirulent and Virulent Strains) by Various
Concentrations of Mouse Lymphokines. Table I 
Effect of Cycloheximide or Emetine on the Inhibition of Rickettsial Growth in L929 cells by Mouse Lymphokines
Time of treatment of L929 cells with lymphokines and/or inhibitor¢
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imide varied in different experiments. For example, in L929 cells treated with lymphokines and/or cycloheximide only after rickettsial infection, percent suppression of the anti-rickettsial effect by cycloheximide was >96% in 3 of 11 experiments, between 45 and 75% in 7 experiments, and 20% in the remaining experiment. When lymphokines and/or cycloheximide were added to L929 cells both before and after infection, percent suppression of the anti-rickettsial effect of the lymphokines by cycloheximide was >90% in two of four experiments and was 18% in the remaining two experiments. Some of this variability may be due to the toxicity of certain lymphokine-cycloheximide combinations for L929 ceils, especially when ceils were treated both before and after infection. Enmtine, another inhibitor of eukaryotic protein synthesis, also suppressed the inhibition of rickettsial growth in L929 cells by mouse lymphokines (Table II) . Species Specificity of the ARA in Mouse and Human Lymphokines. Clearance of R. prowazekii and inhibition of rickettsial growth occurred in mouse lymphokine-treated 3T3-A31 mouse fibroblasts as well as in mouse lymphokine-treated mouse L929 cells (Table III) . However, rickettsial survival and growth were not inhibited in mouse lymphokine-treated human foreskin fibroblasts (Table IIl) or in mouse lymphokinetreated human Flow 5000 cells (data not shown). Similarly, human lymphokine treatment of human foreskin fibroblasts resulted in rickettsial clearance and inhibition of rickettsial growth in these cells, but human lymphokine treatment of mouse L929 cells had no effect on rickettsial survival and growth (Table III) .
Assay of ARA in Mouse Lymphokines. As demonstrated in Table I , it was possible to measure the anti-rickettsial potency of a given mouse lymphokine preparation by determining the effects of dilutions of the preparation on rickettsial survival and growth as measured by %R and RI. This method was very time-consuming; hence we developed a more rapid and convenient scoring method for determining the titer of ARA in lymphokine preparations when the details of the parameters of rickettsial growth were not of special interest (details in Materials and Methods). Fig. 2 $ Not dcto mined.
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V-~,, In Table I , the concentration of ARA at the highest dilution of mouse lymphokines (1:20) was ~1 U/0.3 ml. In Fig. 1 and Tables II and III , mouse lymphokine-treated cells were treated with at least 3 U of ARA/0.3 ml.
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Characterization of the ARA in Mouse Lymphokines. Table IV shows the results of several experiments in which the ARA in crude mouse lymphokines induced with concanavalin A was assayed after the lymphokines were subjected to various treatments. Substantial amounts of the ARA remained after heating the lymphokines at 56°C for 30 rain. However, heating the lymphokines at 80°C for 10 min destroyed II Samples of lymphokines were adjusted to pit 2 with l N ttCI and were allowed to stand at 4°C for 24 h. Lymphokines were then dialyzed against Eagle's minimum essential medium and sterilized by filtration.
the ARA. Treatment of the lymphokines at pH 2 for 24 h followed by dialysis of the lymphokines also resulted in destruction of the ARA.
Discussion
Roles for both specific antibody and sensitized T lymphocytes in anti-rickettsial immunity have been indicated (3, 4, (6) (7) (8) (9) (10) (11) (12) (13) , but the mechanisms of protection have not been well defined. Destruction of antibody-treated rickettsiae occurs within macrophages (4), and destruction of rickettsiae by lymphokine-activated macrophages has also been noted (11) (12) (13) . However, destruction of R. prowazekii by macrophages would seem to be insufficient for eliminating rickettsiae in the host because the endothelial cells (nonprofessional phagocytes) lining the capillaries are major sites of rickettsial multiplication (1) . Destruction of infected cells by sensitized T cells and/or establishment of conditions unsuitable for rickettsial survival and growth in nonprofessional phagocytes would constitute important mechanisms of host defense against R. prowazekii and other Rickettsia species. The former mechanism would require alteration of the membranes of the infected host cells and a cytotoxic mechanism that would not only lyse the altered host cells but also destroy the rickettsiae within these cells. No evidence exists to support such a mechanism of defense in rickettsial infections. The latter mechanism would involve less damage to host tissues, and in vitro correlates of this possible host defense mechanism are provided by the present study. The lymphokines used in this study induced anti-rickettsial conditions in fibroblasts. Thus mediators produced by sensitized cells may function in controlling rickettsial survival and growth in nonprofessional phagocytes in the infected host.
Several features of the lymphokine-rickettsia-host cell interaction deserve further emphasis. First, the lymphokines themselves, which were produced by spleen cells after stimulation with mitogen or antigen, were probably not directly toxic for the rickettsiae: not only were the lymphokines species specific, but the anti-rickettsial effect was suppressed when lymphokines were added to fibroblasts along with an inhibitor of eukaryotic protein synthesis. Second, the development of anti-rickettsial conditions within mouse fibroblasts did not occur immediately after lymphokine addition because rickettsial growth during the first 24 h after infection was more strongly inhibited in cells pretreated with lymphokines for 24 h than in cells treated with lymphokines only after infection. The presence of the lymphokines may be required for continued expression of ARA because the inhibition of rickettsial growth in L929 cells treated with lymphokines both before and after infection was greater than the inhibition observed in cells treated with lymphokines only before infection.
Finally, the avirulent E strain of R. prowazekii was not more susceptible to the antirickettsial conditions induced by lymphokines in fibroblasts than was the virulent Breinl strain.
Induction of microbistatic or microbicidal activity in macrophages or monocytes by lymphokines has been noted by many researchers (12, (22) (23) (24) (25) (26) (27) (28) (29) (30) . In contrast, there have been very few reports of the induction of such activity in nonprofessional phagocytes by lymphokines. One report described the inhibition of the growth of Toxoplasma and Besnoitia in hamster fibroblasts and kidney cells treated with supernatants derived from cultures of antigen-stimulated hamster lymphocytes (31) . Inhibition of the growth of Toxoplasma in mouse L929 cells treated with supernatants obtained from cultures of antigen-stimulated mouse spleen cells has also been noted (32) . The anti-Toxoplasma factor in this system had certain properties in common with interferon-y (32) .
Because the induction of ARA in mouse fibroblasts by mouse lymphokines was inhibited by cycloheximide or emetine, and because mouse and human lymphokines induced ARA in fibroblasts of the homologous species but not in fibroblasts of the heterologous species, the anti-rickettsial factor (or one of the anti-rickettsial factors) in our lymphokine preparations might be an interferon. Inhibition of the growth of R. akari in mouse fibroblasts by virus-induced, pH 2-stable interferon was described over 10 years ago (33) . However, it seems highly unlikely that mouse interferons fl and a are responsible for the ARA of our concanavalin A-induced mouse lymphokine preparations because these interferons are stable at pH 2 (34, 35) , whereas the ARA in our concanavalin A-induced mouse lymphokines was destroyed by exposure to pH 2. The relative stability of the ARA at 56°C also contrasts with the instability of such interferons at 56°C (34) .
Interferon-y, however, remains a possible candidate for all or some of the ARA because it is labile at pH 2 and stable at 56°C (34) . Interferon-y is produced in spleen cell cultures after stimulation with antigens or mitogens (reviewed in 36), and our concanavalin A-induced mouse lymphokine preparations contain antiviral activity that is labile at pH 2 (data not shown). Experiments are currently being conducted in our laboratory to determine the nature of the lymphokines responsible for inhibiting the survival and growth of R. prowazekii in fibroblasts.
Summary
The effect of lymphokine treatment of mouse and human fibroblast cell lines on the growth of Rickettsia prowazekii within the fibroblasts was studied. Treatment of mouse L929 cells with concanavalin A-or antigen-induced mouse lymphokines both before and after infection with R. prowazekii led to clearance of the rickettsiae from a substantial proportion of the cells and suppression of rickettsial growth in those cells which remained infected. Similar but less dramatic anti-rickettsial effects were ohserved in L929 cells treated with mouse iymphokines either only before or after infection with rickettsiae. Mouse lymphokine treatment of L929 cells had similar antirickettsial effects on the avirulent E strain and the virulent Breinl strain of R.
prowazekii. Addition of cycloheximide or emetine to L929 cells at the same time as the lymphokines markedly suppressed the inhibition of rickettsial growth by the lymphokines. Mouse lymphokine treatment inhibited rickettsial survival and growth in mouse 3T3-A31 cells as well as in mouse L929 cells, but had no effect on rickettsial survival and growth in human foreskin fibroblasts. Conversely, concanavalin A-induced human lymphokines inhibited rickettsial survival and growth in human foreskin fibroblasts but had no effect on rickettsial survival and growth in mouse L929 cells. The rickettsia inhibitory activity in concanavalin A-induced mouse lymphokines was destroyed by heating the lymphokines at 80°C for 10 rain or by holding the lymphokines at pH 2 for 24 h but was retained after heating at 56°C for 30 min.
